LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Mountfort Katrina
  2. AU="Horne, Patrick"
  3. AU="Mhurchu, Cliona Ni"
  4. AU="Yatoo, Ali Mohd"
  5. AU="Zhang, Zhiru"
  6. AU="Hadie Adams"
  7. AU="Gaskin, Thomas R"
  8. AU="Guo, Chong"
  9. AU="Guocan Wang"
  10. AU="Catherine Crenn-Hebert"
  11. AU="Alistar, Cristina F"
  12. AU="Makhani, Sarah S"
  13. AU="Tayyeb Pourfallah"
  14. AU="Mauad, Thais"

Suchergebnis

Treffer 1 - 10 von insgesamt 12

Suchoptionen

  1. Artikel: Contemporary Techniques for Coronary Chronic Total Occlusions Revascularisation: Sharing Experience in a Global World: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris Katrina Mountfort, Medical Writer, Radcliffe Cardiology.

    Mountfort, Katrina / Joachim Büttner, Heinz / Yamane, Masahisa / Reifart, Nicolaus / Escaned, Javier / Sianos, Georgios / Goktekin, Omer / Garbo, Roberto

    Interventional cardiology (London, England)

    2018  Band 9, Heft 3, Seite(n) 213–215

    Abstract: Chronic total occlusions (CTO) are the most challenging lesions treated by interventional cardiologists. A symposium at EuroPCR 2014 discussed factors influencing the success of percutaneous intervention (PCI) in CTO. Current treatment paradigms suggest ... ...

    Abstract Chronic total occlusions (CTO) are the most challenging lesions treated by interventional cardiologists. A symposium at EuroPCR 2014 discussed factors influencing the success of percutaneous intervention (PCI) in CTO. Current treatment paradigms suggest that one or two vessel disease should be treated by PCI while three-vessel disease requires surgery if complete revascularisation cannot be achieved with PCI. In patients with CTO and multi-vessel disease timing is key, and evidence of ischaemic burden and expected completeness of revascularisation is required before PCI is undertaken. Other factors affecting procedural success include the available equipment and expertise of the operator. Flexiblity in strategy selection is also important as it is frequently necessary to switch strategies during the procedure. The presentation included two live cases that illustrated the complexity of this procedure.
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/icr.2014.9.3.213
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: A Critical Comparison of Four Test Methods for Determining Overall and Specific Migration from Microwave Susceptor Packaging.

    Mountfort, Katrina / Kelly, Janet / Jickells, Sue M / Castle, Laurence

    Journal of food protection

    2019  Band 59, Heft 5, Seite(n) 534–540

    Abstract: Four approaches for testing for overall migration and specific chemical migration from microwave susceptors were evaluated. The methods used olive oil as a conventional liquid food simulant, a semisolid simulant of olive oil and water absorbed onto ... ...

    Abstract Four approaches for testing for overall migration and specific chemical migration from microwave susceptors were evaluated. The methods used olive oil as a conventional liquid food simulant, a semisolid simulant of olive oil and water absorbed onto diatomaceous earth, Tenax
    Sprache Englisch
    Erscheinungsdatum 2019-06-18
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 243284-5
    ISSN 1944-9097 ; 0362-028X
    ISSN (online) 1944-9097
    ISSN 0362-028X
    DOI 10.4315/0362-028X-59.5.534
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Bonn

    Z 2631: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  3. Artikel ; Online: Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines.

    Mountfort, Katrina / Kuck, Karl-Heinz / Schilling, Richard

    European cardiology

    2018  Band 9, Heft 2, Seite(n) 120–122

    Abstract: A symposium at the 2014 European Society of Cardiology (ESC) congress reviewed the 2012 update of the ESC guideline on rhythm management of atrial fibrillation (AF) patients. The guidelines now include catheter ablation of AF as first-line therapy in ... ...

    Abstract A symposium at the 2014 European Society of Cardiology (ESC) congress reviewed the 2012 update of the ESC guideline on rhythm management of atrial fibrillation (AF) patients. The guidelines now include catheter ablation of AF as first-line therapy in selected patients with symptomatic, paroxysmal AF. A panel comprising electrophysiologists and cardiologists discussed four clinical cases that illustrated the challenges faced in the day-to-day treatment of AF patients and how these guidelines can help inform treatment decisions. Among the key discussions were the importance of early treatment of AF and the dilemma faced in treating AF patients with recently implanted stent, where the risk of stroke must be balanced against the risk of stent thrombosis. The panel considered that among selected patients with paroxysmal AF and no structural heart disease, catheter ablation is reasonable as first-line therapy.
    Sprache Englisch
    Erscheinungsdatum 2018-09-17
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ISSN 1758-3764
    ISSN (online) 1758-3764
    DOI 10.15420/ecr.2014.9.2.120
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  4. Artikel: Patient-tailored Drug-eluting Stent Choice - A Solution for Patients with Diabetes: Proceedings of Two Satellite Symposia Held at EuroPCR in May 2015 in Paris.

    Mountfort, Katrina / Mehran, Roxana / Colombo, Antonio / Stella, Pieter / Romaguera, Rafael / Sardella, Gennaro

    Interventional cardiology (London, England)

    2018  Band 10, Heft 3, Seite(n) 158–161

    Abstract: Although second-generation drug-eluting stents (DES) have improved outcomes in percutaneous coronary interventions (PCIs), important unmet needs remain. Two symposia at EuroPCR 2015 focused on two challenging scenarios. First, patients with diabetes ... ...

    Abstract Although second-generation drug-eluting stents (DES) have improved outcomes in percutaneous coronary interventions (PCIs), important unmet needs remain. Two symposia at EuroPCR 2015 focused on two challenging scenarios. First, patients with diabetes mellitus (DM) have generally inferior outcomes following PCI. The Cre8™ stent (manufactured by CID Spa, member of Alvimedica Group) has shown unique efficacy in subpopulations of patients with DM during clinical trials. A live case in a patient with diabetes illustrated the challenges of complex multivessel disease. Second, optimising stent selection towards devices that have demonstrated complete and early endothelialisation offers the potential to reduce the duration of dual antiplatelet therapy. The Cre8™ DES features a polymer-free platform and has been associated with low rates of in-stent thrombosis.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/ICR.2015.10.03.158
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  5. Artikel: Absorbable Polymer Technology - Viable Solutions for Unmet Needs in PCI: Proceedings of two satellite symposia held at EuroPCR, Paris in May 2015.

    Mountfort, Katrina / Khashaba, Ahmed / Garbo, Roberto / Tigen, Kurstat / Moellmann, Helge / Morice, Marie-Claude

    Interventional cardiology (London, England)

    2018  Band 10, Heft 3, Seite(n) 162–166

    Abstract: The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention procedures, but many challenges remain. In two symposia at EuroPCR 2015, the factors necessary to ensure successful chronic total occlusion (CTO) ... ...

    Abstract The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention procedures, but many challenges remain. In two symposia at EuroPCR 2015, the factors necessary to ensure successful chronic total occlusion (CTO) intervention were presented. Good preparation, sufficient operator experience and the correct approach are key to the success of CTO interventions. A live case demonstrated the challenges of these complex cases. Stent choice in CTO interventions is crucial; second-generation DES are associated with lower rates of restenosis and re-occlusion compared with first-generation DES. The Coracto™ DES features unique structural properties and rapidly absorbable polymer, resulting in excellent conformability, efficacy and safety.
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/ICR.2015.10.03.162
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  6. Artikel: Meeting the Unmet - The Cre8 Polymer-free Drug-eluting Stents Technology: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris.

    Mountfort, Katrina / Carrié, Didier / Valgimigli, Marco / Sardella, Gennaro / Banai, Shmuel / Romaguera, Rafael / Stella, Pieter

    Interventional cardiology (London, England)

    2018  Band 9, Heft 3, Seite(n) 184–189

    Abstract: The use of first-generation drug-eluting stents (DES) has been associated with safety concerns such as very late stent thrombosis. Today, with the release of newer DES, there is a need for comparative studies of percutaneous coronary intervention (PCI) ... ...

    Abstract The use of first-generation drug-eluting stents (DES) has been associated with safety concerns such as very late stent thrombosis. Today, with the release of newer DES, there is a need for comparative studies of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) to demonstrate their value in patients with high risk of restenosis such as diabetic patients. In a satellite symposium presented at EuroPCR 2014, the Cre8™ DES was discussed. The Cre8 device has a number of unique clinical features, including polymer-free technology, abluminal reservoir technology and bio-inducer surface that ensure effective neointima suppression and rapid endothelialisation. The efficacy of the Cre8 DES has been demonstrated in the International randomised comparison between DES Limus Carbostent and Taxus drug-eluting stents in the treatment of de novo coronary lesions (NEXT) randomised clinical study, with equivalent efficacy in the diabetic and general populations, a unique finding. Ongoing clinical studies such as Investig8 and the Tel Aviv Medical Center (TLVMC) Cre8 study have confirmed the efficacy of the device in patient populations with a high proportion of diabetic patients. The Demonstr8 randomised trial has shown almost complete Cre8 strut coverage at three months with a numerical advantage versus bare metal stent (bare metal stents [BMS] - comparator device) at one month. In addition, use of the Cre8 DES may enable a shorter duration of dual antiplatelet therapy (DAPT) following PCI. The Cre8 DES therefore represents a significant advance in stent technology and may be particularly useful in challenging clinical settings.
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/icr.2014.9.3.184
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  7. Artikel: The Promise of Leadless Pacing: Based on Presentations at Nanostim Sponsored Symposium Held at the European Society of Cardiology Congress 2013, Amsterdam, The Netherlands, 2 September 2013.

    Mountfort, Katrina / Knops, Reinoud / Sperzel, Johannes / Neuzil, Petr

    Arrhythmia & electrophysiology review

    2014  Band 3, Heft 1, Seite(n) 51–55

    Abstract: Pacemaker technologies have advanced dramatically over the decades since they were first introduced, and every year many thousands of new implants are performed worldwide. However, there continues to be a high incidence of acute and chronic complications, ...

    Abstract Pacemaker technologies have advanced dramatically over the decades since they were first introduced, and every year many thousands of new implants are performed worldwide. However, there continues to be a high incidence of acute and chronic complications, most of which are linked to the lead or the surgical pocket created to hold the device. A leadless pacemaker offers the possibility of bypassing these complications, but requires a catheter-based delivery system and a means of retrieval at the end of the device's life, as well as a way of repositioning to achieve satisfactory pacing thresholds and R waves, a communication system and low peak energy requirements. A completely self-contained leadless pacemaker has recently been developed, and its key characteristics are discussed, along with the results of an efficacy and safety trial in an animal model. The results of the LEADLESS study, the first human trial to look at safety and feasibility of the leadless device, are discussed and the possible implications for future clinical practice examined.
    Sprache Englisch
    Erscheinungsdatum 2014-05-30
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813970-7
    ISSN 2050-3377 ; 2050-3369
    ISSN (online) 2050-3377
    ISSN 2050-3369
    DOI 10.15420/aer.2011.3.1.51
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  8. Artikel: MGuard Embolic Protection Stent - The Importance of Thrombus Management in ST-elevation Myocardial Infarction Primary Percutaneous Coronary Intervention: Proceedings of STEMI symposium at EuroPCR on 20-23rd May 2014 in Paris.

    Mountfort, Katrina / Costa, Ricardo / Abizaid, Alexandre / Fajadet, Jean / Lotan, Chaim / Kornowski, Ran / Dudek, Dariusz / Henriques, Jose Ps / Amoroso, Giovanni

    Interventional cardiology (London, England)

    2018  Band 9, Heft 3, Seite(n) 168–174

    Abstract: Distal embolisation of atherothrombotic material is a frequent consequence of percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). This causes microvascular occlusions, leading to a further reduction in myocardial ... ...

    Abstract Distal embolisation of atherothrombotic material is a frequent consequence of percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). This causes microvascular occlusions, leading to a further reduction in myocardial reperfusion. The MGuard™ embolic protection stent (EPS) features a unique polymer micronet mesh coating. When used in acute STEMI, the MGuard EPS shows significant improvement in myocardial flow and ST resolution, even in complicated clinical cases vs the standard approach with conventional bare metal or drug-eluting stents. Data from the andomised Safety and Efficacy Study of MGuard Stent After a Heart Attack (MASTER II) trial and from a real-life registry have shown the efficacy and safety of the MGuard in primary PCI. This report of the proceedings of a symposium at EuroPCR, 20-23 May 2014, Paris, France, discussed clinical trial data, as well as a number of clinical cases, illustrating the utility of the MGuard EPS in difficult situations.
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/icr.2014.9.3.168
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  9. Artikel: Cre8™ Unique Technology in Challenging Daily Practice: Proceedings of a satellite symposium held at EuroPCR on 20th - 23rd May 2014 in Paris.

    Mountfort, Katrina / Antoniucci, David / Mehran, Roxana / DeLuca, Giuseppe / Nef, Holger / Vrolix, Mathias / Khashaba, Ahmed

    Interventional cardiology (London, England)

    2018  Band 9, Heft 3, Seite(n) 180–183

    Abstract: The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including ... ...

    Abstract The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.
    Sprache Englisch
    Erscheinungsdatum 2018-03-23
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/icr.2014.9.3.180
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  10. Artikel: Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.

    Mountfort, Katrina / Mahfoud, Felix / Schmieder, Roland / Davies, Justin / Kandzari, David E / Weil, Joachim / Whitbourn, Robert

    Interventional cardiology (London, England)

    2018  Band 8, Heft 2, Seite(n) 118–123

    Abstract: Hypertension is one of the most prevalent chronic diseases worldwide and the incidence of resistant hypertension is increasing. Catheter-based renal denervation (RDN) offers a new approach to reaching blood pressure goals by targeting the renal nerves. ... ...

    Abstract Hypertension is one of the most prevalent chronic diseases worldwide and the incidence of resistant hypertension is increasing. Catheter-based renal denervation (RDN) offers a new approach to reaching blood pressure goals by targeting the renal nerves. The technique has demonstrated significant and sustained reductions in blood pressure (BP) in the Symplicity HTN-1 and Symplicity HTN-2 clinical trials. The Global SYMPLICITY Registry aims to demonstrate safety and effectiveness in a 'real-world' patient population. Real-world RDN experience has emphasised that patient selection is crucial to successful outcomes; a multidisciplinary referral network is recommended to increase awareness of the procedure and identify patients who are likely to respond best to RDN. Further advances in catheter technology have led to the development of the multi-electrode Symplicity Spyral™ multi-electrode catheter; preliminary data from the feasibility study using the Symplicity Spyral catheter indicate clinical efficacy and procedural safety with reduced procedure times. The Symplicity Spyral catheter is not yet commercially available. The indications of RDN may also expand beyond resistant hypertension - encouraging data have been seen in patients with moderate treatment resistant hypertension. Furthermore, RDN may be beneficial in other clinical states characterised by sympathetic nervous system overactivation including heart failure and chronic kidney disease. Additional data are needed to evaluate the efficacy of RDN in these disease states.
    Sprache Englisch
    Erscheinungsdatum 2018-01-11
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2813989-6
    ISSN 1756-1485 ; 1756-1477
    ISSN (online) 1756-1485
    ISSN 1756-1477
    DOI 10.15420/icr.2013.8.2.118
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang